Jaguar Health
JAGX
2 hedge funds and large institutions have $31.9M invested in Jaguar Health in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
133% more call options, than puts
Call options by funds: $1.15M | Put options by funds: $494K
132% more capital invested
Capital invested by funds: $13.7M → $31.9M (+$18.1M)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$17.1M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$462K |
| 2 |
ECM
ExodusPoint Capital Management
New York
|
-$200K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$165K |
| 4 |
Barclays
London,
United Kingdom
|
-$151K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
-$122K |
JAGX Hedge Fund Activity: Q2 2021 in Review
2 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Jaguar Health (JAGX) for Q2 2021, worth a combined $31.9M — up 132% from $13.7M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new JAGX positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $17.1M. The largest seller was HRT Financial, cutting an estimated $462K.
- 2 institutional investors held Jaguar Health (JAGX) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $31.9M of Jaguar Health stock for Q2 2021, up 132% quarter-over-quarter.
- 2 funds opened new Jaguar Health positions in Q2 2021 and 0 closed out, a net change of +2 holders.
- The largest Jaguar Health buyer in Q2 2021 was Renaissance Technologies, an estimated $17.1M added.
- The largest Jaguar Health seller in Q2 2021 was HRT Financial, an estimated $462K sold.
Based on aggregated 13F filings for Q2 2021.